TEVA News and Press, Teva Pharmaceutical Industries Limited American Depositary Shares From 06/04/24

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Goldman Sachs 45 th Annual Global Healthcare Conference on Tuesday, June 11, 2024. The presentation will begin at 8:00 A.M. Eastern Time. To access...

Switching to UZEDY at four weeks after the last dose of once-monthly paliperidone palmitate provided the most comparable pharmacokinetic (PK) profile based on the relevant PK modeling data Additional data include new Phase 3 RISE and SHINE analyses demonstrating no new or unexpected safet...

Nearly 98% of patients experience quality of life impact as a result of tardive dyskinesia (TD) including social, psychological, physical and recreational aspects of daily living Data highlight for the first time that TD has a multidimensional impact on patients including those with mild ...

2024-05-30 07:33:56 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript) Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results Teva: Sustained Revenue Growth Amid Financial Stra...

U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day) AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 (VMAT2) inhibitor for effective and tolerable tardive dyskinesia (TD) and Huntington’s di...

2024-05-28 18:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-23 16:16:31 ET More on ADHD drugs New ADHD drugs could pay off for pharmaceutical companies Drug shortages in U.S. at highest level on record since 2001 Adderall shortage prompts FDA, DEA to ask for production boost Read the full article...

2024-05-22 08:45:00 ET Summary Walgreens Boots Alliance stock declined by 6.4% to a 25-year low of $16.68, a price not seen since 1998. Short interest, potential dividend cuts, and lingering ex-CEO worries are among reasons for the decline. Walgreens value grades compared to t...

2024-05-21 06:53:48 ET Summary Abrams' 13F portfolio value decreased from $3.22B to $3.20B this quarter. The number of holdings in the portfolio decreased from 14 to 12. The top three stakes in the portfolio make up approximately 48% of the total, while the top five holdings m...

2024-05-21 06:51:13 ET More on AbbVie, Alvotech, etc. AbbVie, Inc. (ABBV) Bank of America Health Care Conference Call Transcript Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript) Teva Pharmaceutical: 6 Takeaways Fr...